Roche Breast-Cancer Drug Perjeta Showed Prolong Survival Rate

September 28, 2014 7:26 PM

3 0

Roche Breast-Cancer Drug Perjeta Showed Prolong Survival Rate

Researchers reported on Sunday that a drug treating advanced breast cancer has shown pioneering success in extending lives in a clinical trial.

Experts recommended its extensive use for women with an aggressive form of the disease.

Read more

To category page

Loading...